N.n. Petrov National Medical Research Center Of Oncology
Clinical trials sponsored by N.n. Petrov National Medical Research Center Of Oncology, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Massive cancer survival study launched in russia Results expected Dec 2026 (estimated)
- Older women with Low-Risk breast cancer may avoid unnecessary surgery Results expected May 2027 (estimated)
-
Can a Two-Drug chemo combo shrink BRCA breast tumors before surgery?
Disease control OngoingResearchers test whether giving mitomycin plus carboplatin before surgery helps people with BRCA1 or BRCA2 mutations and locally advanced triple-negative breast cancer. The trial compares this combination, followed by paclitaxel, against standard chemotherapy. About 30 adults wit…
Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Head-to-Head chemo showdown for rare lymphoma
Disease control By invitation onlyThis phase 3 trial compares four different chemotherapy combinations to see which works best as a first treatment for peripheral T-cell lymphoma. About 114 newly diagnosed patients will receive one of the regimens, and researchers will measure how many achieve complete remission …
Phase 3 • Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Massive cancer survival study launched in russia
Knowledge-focused OngoingThis study looks at survival rates for people with cancers like melanoma, breast, colon, and lung cancer using data from Russian cancer registries. It includes 100,000 people of any age. The goal is to understand survival trends to help improve cancer care, not to test a new trea…
Sponsor: N.N. Petrov National Medical Research Center of Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC